Palisade Bio (PALI) Other Operating Expenses (2010 - 2026)

Palisade Bio (PALI) has reported Other Operating Expenses for 10 consecutive years, with -$3.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Operating Expenses fell 183.67% year-over-year to -$3.8 million; the TTM figure through Mar 2026 stood at -$10.1 million (down 84.51% YoY), while the FY2025 annual figure was -$7.6 million, down 38.37% from the prior year.
• Other Operating Expenses eased to -$3.8 million in Q1 2026 per PALI's latest filing, from -$3.6 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $12.5 million in Q4 2024 and bottomed at -$15.1 million in Q3 2024.
• Historically, Other Operating Expenses has averaged -$1.4 million across 5 years, with a median of -$1.4 million in 2024.
• Annual changes were most pronounced in 2024 — Other Operating Expenses surged 911.35% — and 2026, when it slumped 183.67%.
• Palisade Bio's Other Operating Expenses stood at $410000.0 in 2022, then jumped by 200.98% to $1.2 million in 2023, then soared by 911.35% to $12.5 million in 2024, then plunged by 128.61% to -$3.6 million in 2025, then slipped by 7.03% to -$3.8 million in 2026.
• Business Quant data shows PALI's Other Operating Expenses at -$3.8 million in Q1 2026, -$3.6 million in Q4 2025, and -$1.5 million in Q3 2025.